Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kangji Medical Holdings Limited ( (HK:9997) ) has shared an announcement.
Kangji Medical Holdings Limited has announced a proposal for its privatization through a scheme of arrangement sanctioned by the Grand Court. This move includes the withdrawal of the company’s listing and involves a special deal concerning a rollover arrangement and shareholders’ agreement. The scheme’s sanctioning by the Grand Court marks a significant step in the process, with the proposal set to become effective upon the fulfillment of certain conditions. This development could impact the company’s operations and market positioning, affecting stakeholders and potentially altering its strategic direction.
The most recent analyst rating on (HK:9997) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Kangji Medical Holdings Limited stock, see the HK:9997 Stock Forecast page.
More about Kangji Medical Holdings Limited
Kangji Medical Holdings Limited is a company incorporated in the Cayman Islands, operating in the medical industry. It focuses on providing medical devices and solutions, with a particular emphasis on surgical instruments and related products.
YTD Price Performance: 51.84%
Average Trading Volume: 2,817,616
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.87B
For a thorough assessment of 9997 stock, go to TipRanks’ Stock Analysis page.